Abstract
Non-ST elevation acute myocardial infarction (AMI) complicates around 10% of emergency department (ED) presentations for acute heart failure (AHF), while non-ischemic troponin elevation occurs in over 40%. We had two primary objectives: 1. Validate the recently-derived 2-variable non-ischemic troponin rule out in AHF (NITRO-AHF) clinical decision instrument (CDI) for predicting AMI or 30-day revascularization, and 2. Test whether addition of serial troponin measurement adds value to the original CDI.
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
